Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C-Reference-Cited by-同舟云学术

Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C

Published:2020-10 Issue:5 Volume:2 Page:100138
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Itakura Jun,Kurosaki Masayuki,Kakizaki Satoru,Amano Keisuke,Nakayama Nobuaki,Inoue Jun,Endo Tetsu,Marusawa Hiroyuki,Hasebe Chitomi,Joko Kouji,Wada Shuichi,Akahane Takehiro,Koushima Youhei,Ogawa Chikara,Kanto Tatsuya,Mizokami Masashi,Izumi Namiki

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference29 articles.

1. Daclatasvir plus asunaprevir treatment for real-world HCV genotype 1-infected patients in Japan;Kanda;Int J Med Sci,2016

2. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan;Suzuki;Hepatol Int,2018

3. Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group;Tsuji;J Gastroenterol,2018

4. Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for HCV genotype 1b-infected Japanese patients with or without cirrhosis;Kumada;Hepatology,2015

5. The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study;Kumada;J Gastroenterol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors;Scientific Reports;2024-07-16

2. Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase;Expert Opinion on Investigational Drugs;2024-01-02

3. Antimicrobial resistance – Impact on humans;Encyclopedia of Toxicology;2024

4. Drug Resistance to HCV in Direct-Acting Antiviral Treatments;Viral Hepatitis Journal;2023-12-26

5. Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections;Diagnostics;2023-09-30